Systematic Alpha Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Systematic Alpha Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-24,500	Closed	-$359K	–	220
2024 Q1	$359K	Hold	24,500	–	–	0.01%	176
2023 Q4	$341K	Hold	24,500	–	–	0.02%	178
2023 Q3	$328K	Hold	24,500	–	–	0.02%	170
2023 Q2	$309K	Hold	24,500	–	–	0.02%	180
2023 Q1	$279K	Hold	24,500	–	–	0.01%	188
2022 Q4	$254K	Hold	24,500	–	–	0.01%	193
2022 Q3	$256K	Hold	24,500	–	–	0.02%	188
2022 Q2	$271K	Hold	24,500	–	–	0.02%	188
2022 Q1	$273K	Hold	24,500	–	–	0.01%	206
2021 Q4	$321K	Hold	24,500	–	–	0.01%	188
2021 Q3	$301K	Hold	24,500	–	–	0.01%	204
2021 Q2	$312K	Buy	+24,500	New	+$343K	0.01%	165

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Systematic Alpha Investments's RDY Position: Q2 2024 in Review

Systematic Alpha Investments sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 24,500 shares — an estimated $359K sold.

Systematic Alpha Investments first reported a position in RDY in Q2 2021 and held it in 12 quarters. The position peaked at $359K in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

Systematic Alpha Investments reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
Systematic Alpha Investments sold 24,500 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $359K.
Systematic Alpha Investments first reported a position in Dr. Reddy's Laboratories in Q2 2021 and held it in 12 quarters.
Systematic Alpha Investments's Dr. Reddy's Laboratories position peaked at $359K in Q1 2024.
222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Systematic Alpha Investments's 13F filing for Q2 2024, filed 12 Aug 2024.